RXST Q4 2024 Earnings — RxSight, Inc. Revenue & Financial Results | Market Cap Arena

RXSTRxSight, Inc.

$313M

Q4 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$40M+40.7% YoY

Gross Profit

$29M71.6% margin

Operating Income

-$9M-21.5% margin

Net Income

-$6M-14.8% margin

EPS (Diluted)

$-0.15

QoQ Revenue Growth

-11.4%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$5M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$319M

Total Liabilities

$37M

Stockholders' Equity

$281M

Cash & Equivalents

$17M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$40M	$29M	+40.7%
Gross Profit	$29M	$18M	+63.1%
Operating Income	-$9M	-$11M	+20.5%
Net Income	-$6M	-$9M	+35.3%

Revenue Segments

L D D

$11M91%

Service Warranty Service Contracts And Accessories

$1M9%